Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
12112studies shown
Showing 3,253-3,264 of 12,112
Other study type icon
RecruitingNCT05591937

S.T.A.N.D. Alacrity Center Signature Project

This study is recruiting. It focuses on anxiety and currently lists participation information in the United States.

In Los Angeles
Anxiety, DepressionOtherFrom 18 Years to 40 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Anxiety, Depression
Other study type icon
RecruitingNCT06640803

Sacramento Clinical High Risk for Psychosis Stepped-Care Program

This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.

Multiple locations, including Elk Grove
SchizophreniaOtherFrom 12 Years to 25 Years
Countries
United States
Sponsor
University of California, Davis
Condition
Schizophrenia
Other study type icon
RecruitingNCT04752618

Safe Mothers, Safe Children Initiative

This study is recruiting. It focuses on PTSD and currently lists participation information in the United States.

In New York
PTSD, DepressionOtherOver 18 Years
Countries
United States
Sponsor
New York University
Condition
PTSD, Depression
Other study type icon
RecruitingNCT05184335

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.

Multiple locations, including Phoenix
SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Reviva Pharmaceuticals
Condition
Schizophrenia
Drug study icon
RecruitingNCT07499440

Safety and Efficacy of HB-1 for PTSD

This study is recruiting. It focuses on PTSD and currently lists participation information in Australia.

Multiple locations, including Bruce
PTSDDrugFrom 18 Years to 65 Years
Countries
Australia
Sponsor
HB BioTech, LLC
Condition
PTSD
Drug study icon
RecruitingISRCTN64695913

Safety and efficacy study of two doses of lurasidone in acutely psychotic subjects with schizophrenia (PEARL 3)

This study is recruiting. It focuses on schizophrenia and currently lists participation information in Colombia, Germany, India, the Philippines, Romania, Russian Federation, Ukraine, and the United States.

In Colombia
SchizophreniaOtherOver 18 Years
Countries
United States, Colombia, Germany, ...
Sponsor
Dainippon Sumitomo Pharma America Inc. (USA)
Condition
Schizophrenia
Drug study icon
RecruitingNCT05648591

Safety and Tolerability of Open-Labeled Iloperidone in Adolescents

This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.

Multiple locations, including Little Rock
Schizophrenia, BipolarityDrugFrom 12 Years to 17 Years
Countries
United States
Sponsor
Vanda Pharmaceuticals
Condition
Schizophrenia, Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.